Abstract PO2-20-03: VERITAC-3: A Randomized Phase 3 Study, with a Lead-In, of First-Line Vepdegestrant + Palbociclib Vs Letrozole + Palbociclib in Estrogen Receptor–positive/human Epidermal Growth Factor Receptor 2–negative Advanced Breast Cancer
Cancer Research(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined